Bone Marrow Transplant From Related Donor for Patients With High Risk Hemoglobinopathies
Status:
Terminated
Trial end date:
2003-11-21
Target enrollment:
Participant gender:
Summary
The major goal of this study is to determine the risks and benefits of bone marrow
transplants in patients with severe thalassemia or sickle cell disease. Participation in this
project will be for two years.
Phase:
Phase 2
Details
Lead Sponsor:
Baylor College of Medicine
Collaborators:
Center for Cell and Gene Therapy, Baylor College of Medicine Texas Children's Hospital The Methodist Hospital Research Institute The Methodist Hospital System